Clinical Research Directory
Browse clinical research sites, groups, and studies.
COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate Cancer
Sponsor: Samsung Medical Center
Summary
In local advanced prostate cancer patients with clinically positive metastatic regional lymph node, the optimal treatment is still unanswered. For these patients, radiotherapy combined with hormonal therapy or hormonal therapy alone are recommended. Recently, the reports from NCCB and SEER data showed that radiotherapy combined with hormonal therapy have better survivals than hormonal therapy alone. This randomized phase III trial compare hormonal therapy alone with combined hormone with radiotherapy in clinically pelvic lymph node metastatic prostate cancer.
Official title: Open Label, Randomized Phase III Trial of Hormone Therapy Alone Versus COmbined HOrmone With Radiation Therapy in Clinical Pelvic Lymph Node Metastatic Prostate Cancer (COHORT Trial)
Key Details
Gender
MALE
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
61
Start Date
2016-01-15
Completion Date
2026-12-14
Last Updated
2023-11-27
Healthy Volunteers
Yes
Conditions
Interventions
Intensity modulated radiotherapy
Locations (1)
Samsung Medical Center
Seoul, South Korea